Vaccinex reports Q4 results
Slightly above 67% of Vaccinex's investor base is looking to short. The analysis of overall sentiment of trading Vaccinex stock suggests that many investors are alarmed at this time. Vaccinex's investing sentiment can be driven by a variety of factors including economic data, Vaccinex's earnings reports, geopolitical events, and overall market trends.
Vaccinex |
Vaccinex secures 17.9 million in new financing and holds 1.5 million in cash and marketable securities as of December 31, 2023.
Read at seekingalpha.com
 |
Vaccinex Fundamental Analysis
We analyze Vaccinex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaccinex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaccinex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Vaccinex is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Vaccinex Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaccinex stock to make a market-neutral strategy. Peer analysis of Vaccinex could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics with similar companies.
Peers
Vaccinex Related Equities
| FBRX | Forte Biosciences | 3.67 | ||||
| TARA | Protara Therapeutics | 0.88 | ||||
| ELDN | Eledon Pharmaceuticals | 1.76 | ||||
| ERAS | Erasca | 1.94 | ||||
| RNXT | RenovoRx | 1.96 | ||||
| MNPR | Monopar Therapeutics | 2.56 | ||||
| ANEB | Anebulo Pharmaceuticals | 2.86 | ||||
| SRZN | Surrozen | 3.34 | ||||
| SABS | SAB Biotherapeutics | 4.52 | ||||
| SLRX | Salarius Pharmaceuticals | 6.52 | ||||
| GOVX | GeoVax Labs | 12.60 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |